Ovarian tumor
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients in whom an ovarian tumor was detected by preoperative ultrasound (including lesions arising from the ovarian adnexa and fallopian tube) and who were ultimately confirmed by surgical pathology to have a non-physiological cyst; 2.Patients who underwent surgical treatment and had a pathological diagnosis; 3.The interval between ultrasound examination and surgery was no more than 30 days; 4.Patients with no prior history of ovarian cancer; 5.The interval between serum tumor marker CA125 testing and surgery was no more than 30 days. 6.The interval between exosomal OCS measurement and serum tumor marker CA125 testing and surgery must not exceed 30 days (prospective cohort only).
Exclusion criteria
Exclusion criteria: 1.Pregnant patients; 2.Patients who declined surgery after admission for personal reasons or underwent surgery at another hospital; 3.Cases in which surgical pathology confirmed broad ligament fibroids; 4.Cases in which surgical pathology showed only a physiological cyst; 5.Cases with indeterminate histopathological results; 6.Any congenital conditions involving abnormal ovarian development or gonadal dysgenesis (including but not limited to intersex disorders); 7.Patients diagnosed with a malignant tumor who had not achieved complete remission (CR), or who had achieved CR but had an interval of less than 1 year since the last chemotherapy; 8.Patients who participated in an interventional clinical trial before enrollment that could affect the determination of the primary outcome; 9.Preoperative ultrasound images of inadequate quality (images not retained or image quality too poor);
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Multi-Class Area Under the (ROC) Curve; | — |
Countries
China
Contacts
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine